A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/21 (2006.01) C07K 14/57 (2006.01)
Patent
CA 2613737
The present invention provides IFN.alpha.2 mutants and active fragments, analogs, derivatives, and variants thereof that have improved specific agonist or antagonist activity as compared to wild-type IFN.alpha.2. The present invention further provides pharmaceutical compositions comprising IFN.alpha.2 mutants useful for treating or preventing cancer, autoimmune diseases, infectious diseases or disorders associated with increased expression of IFN.alpha.2.
La présente invention concerne des mutants IFNa2 et des fragments actifs, des analogues, des dérivés et des variants de ceux-ci qui possèdent une activité agoniste ou antagoniste spécifique améliorée comparée à IFNa2 de type sauvage. Cette invention concerne aussi des compositions pharmaceutiques comprenant des mutants IFNa2 qui conviennent pour traiter ou prévenir le cancer, des maladies auto-immunes, des maladies infectieuses ou des pathologies associées à une expression accrue de IFNa2.
Jaitin Diego
Kalie Eyal
Roisman Laila C.
Schreiber Gideon
Ltd. Yeda Research And Development Co.
Ridout & Maybee Llp
LandOfFree
Recombinant interferon .alpha.2 (if.alpha.2) mutants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant interferon .alpha.2 (if.alpha.2) mutants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant interferon .alpha.2 (if.alpha.2) mutants will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1960420